CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Increasing cases of food mislabelling and strengthening the healthcare
recommendations
4.1.2. Genetic disorders, obesity, sleep disorders, high blood pressure levels and
changing lifestyle
4.1.3. Greater exposure to the site of application and high operative success rates
4.1.4. Minimally invasive nature, reduced treatment time, and the introduction of the
medical adhesives to close the affected site
4.2. Market Restraints & Challenges
4.2.1. The high cost of varicose vein treatment procedures and difficulty in maintaining sustainability
4.2.2. Lack of training for vascular surgeons and the implementation of health care reforms
4.2.3. Inconsistent reimbursement scenario
CHAPTER 5 GLOBAL VARICOSE VEIN TREATMENT MARKET – BY PRODUCT
5.1. Venous Closure Products
5.2. Surgical Products
5.3. Ablation Devices
5.3.1. Laser Ablation Devices
5.3.2. Radiofrequency Ablation Devices
CHAPTER 6 GLOBAL VARICOSE VEIN TREATMENT MARKET – BY TREATMENT MODE
6.1. Injection Sclerotherapy
6.2. Surgical Ligation/Stripping
6.3. Endovenous Ablation
CHAPTER 7 GLOBAL VARICOSE VEIN TREATMENT MARKET – BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8 GLOBAL VARICOSE VEIN TREATMENT MARKET - COMPANY PROFILES
8.1. B.Braun Melsungen AG
8.2. Vascular Solutions, Inc.
8.3. Dornier MedTech GmbH
8.4. AngioDynamics, Inc.
8.5. Syneron Medical Ltd.
8.6. VNUS Medical Technologies, Inc.
8.7. Astra Tech, Inc.
8.8. Medtronic PLC
8.9. Kreussler, Inc.
8.10. InaVein, LLC
8.11. Lumenis Ltd.
8.12. Biolitec AG
CHAPTER 9 GLOBAL VARICOSE VEIN TREATMENT MARKET – COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10 MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11 APPENDIX
11.1. List of Tables
11.2. List of Figures